Search
for
Sort by
Research 211–240 of 1000+
- Efficacy of Janus kinase inhibitors in adult patients with alopecia areata
- BH09 Patient experience of off-label Janus kinase inhibitor use for alopecia areata in a cohort of 34 patients from a single UK practitioner: exploring changing trends in healthcare provision and access to drug treatments
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- Janus kinase inhibitor as a therapeutic option in alopecia areata. Case report
- Janus Kinase Inhibitors - A next generation treatment in Dermatology
- P123 : Oral Janus kinase inhibitors for the treatment of alopecia areata: a systematic review and metaanalysis
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- 865 Conditional ablation of JAK-STAT5 signaling induces anagen hair growth
- Janus kinase (JAK)
- Minoxidil Sulfate Regulates JAK / STAT Signalling and Mitochondrial Function in Alopecia Areata
- Multiomic Characterization of Treatment Response to JAK Inhibition in Patients with APECED
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Komplet remission ved behandling med JAK-hæmmer hos en patient med alopeciatotalis
- 378 Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- Alopecia Areata, triggered by psychological stress and successfully treated with a Janus kinase inhibitor. Case report
- Inhibidor janus kinasa como opción terapéutica en alopecia areata. Reporte de caso
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- 1359 Hair growth is induced by blockade of macrophage-derived oncostatin M and downstream JAK-STAT5 signaling in hair follicle stem cells
- Age-associated inflammation inhibits epidermal stem cell function
- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Alopecia areata
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management